A new phytochemical study of Mortonia greggii (Celastraceae) afforded four friedelan derivatives (1Ð4), three lupanes (5Ð7), retusine (8), two esterified polyhydroxyagarofurans (9Ð10), mortonin C (11) and photomortonin C (12). The anti-inflammatory activity on carrageenan and 12-O-tetradecanoylphorbol-13-acetate induced models of inflammation, as well as the ability to inhibit the nitric oxide (NO) produced by lipopolysaccharide-stimulated mouse peritoneal macrophages were evaluated for the main metabolites. Our results showed that the friedelan dehydrocanophyllic acid methyl ester (1) exhibits an anti-inflammatory effect which could be related to an inhibition of prostaglandin and NO production. The activity of lupeol (5), 29-hydroxylupeol (6) and 29-hydroxylupenone (7) might be involved with the prostanoid synthesis. The presence of the hydroxy groups in 6 appears to be important for activity. The edema inhibition capacity of retusine (8) could be related to a reduction of the prostaglandin production. The agarofuran derivative 10 is an NO inhibitor whose activity is probably not involved in the synthesis of prostaglandins.
Introduction
The genus Mortonia (Celastraceae) is formed by five species endemic to the arid lands of northern Mexico and southern United States. Previous studies of this genus have shown the presence of triterpenes and polyhydroxyagarofuran esters as its main secondary metabolites . The antiinflammatory activity of a large number of terpenoids has been described and many of them have been identified as the active principles of plants used in folk medicine (Mahato et al., 1992; Safayhi and Sailer, 1997) . On the other hand, some pentacyclic triterpenes had been reported as important inhibitors of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) enzymes (Ferná ndez et al., 2001) . These inducible enzymes are implicated in the overproduction of prostaglandins and nitric oxide (NO), which play important roles in the modulation of the inflammatory response (Rioja et al., 2000; Sautebin et al., 1995) . The nature of the triterpenoid receptor remains unknown and, therefore, it is necessary to study the structure-activity relationships, which at present are poorly understood, to elucidate their mechanism of action (Suh et al., 1998) . The aim of the present study of M. greggii was to evaluate the anti-inflammatory effects of its main metabolites in two models of acute inflammation as well as to elucidate their influence on the NO generated by lipopolysaccharide (LPS) activated mouse peritoneal macrophages (Mφ).
Materials and Methods

Plant material
Mortonia greggii Gray was collected in Presa Maltos, Nuevo Leon, Mexico in November 1998. A voucher specimen (IZTA 27517) was deposited at the Izta Herbarium, UNAM, Campus Iztacala.
Isolation of terpenoid compounds
Dried and ground roots (265 g) and leaves (630 g) were extracted with hexane and acetone successively. Solvents were removed under reduced pressure and extracts submitted to vacuum column chromatography (VCC) over silica gel (60G Merck) or preparative TLC on 20 cm ¥ 20 cm, 2.0 mm plates.
The hexanic root extract (8.0 g) was purified by VCC (30 ¥ 6.0 cm, 120 g). Elution was performed by taking 125 ml fractions starting with hexane (frs 1Ð10) followed by hexane/EtOAc 97:3 v/v (frs 11Ð 40), hexane/EtOAc 95:5 v/v (frs 41Ð60), hexane/ EtOAc 9:1 v/v (frs 61Ð75), hexane/EtOAc 8:2 v/v (frs 76Ð95), hexane/EtOAc 1:1 v/v (frs 96Ð150), and EtOAc. Fractions 65Ð75 (1.6 g) were submitted to a new VCC (30 ¥ 2.5 cm, 24 g) eluted with CH 2 Cl 2 /EtOAc 9:1 v/v to obtain dehydrocanophyllic acid (4) (m.p. 308 Ð 310 ∞C, α D Ð 38∞, c 0.20 CHCl 3 , 400 mg) (Ahmad and Atta-ur-Rahman, 1994 ) and fraction A. Further purification of A (500 mg) by VCC (20 ¥ 1.5 cm, 7.5 g), using CH 2 Cl 2 /EtOAc 9:1 v/v as eluent afforded 3 (m.p. 270Ð273 ∞C, α D Ð 22.5∞, c 0.11 CHCl 3 , 50 mg) (Betancor et al., 1980) (Tinto et al., 1992) . Fractions 63Ð75 (5.3 g) produced, after a VCC (30 ¥ 5.0 cm, 75 g) in hexane/EtOAc 9:1 v/v, 3 (325 mg) and retusine (8) (yellow needles from hexane/EtOAc, m.p. 160Ð162 ∞C, 160 mg) (Vidari et al., 1971) . Compound 29-hydroxylupeol (6) (m.p. 230Ð232 ∞C, α D Ð 13∞, c 0.18 CHCl 3 , 820 mg) (Betancor et al., 1980) was separated from fractions 72Ð76.
The acetonic leaf extract (80 g) was purified by VCC (30 ¥ 10 cm, 700 g). Elution was performed by taking 1000 ml fractions as follows: hexane (frs 1Ð3), hexane/EtOAc 9:1 v/v (frs 4Ð80), hexane/ EtOAc 8:2 v/v (frs 81Ð105), hexane/EtOAc 7:3 v/v (frs 106Ð120), hexane/EtOAc 1:1 v/v (frs 121Ð 140), and EtOAc. From fractions 6Ð8, compound lupeol (5) (m.p. 211Ð213 ∞C, α D 22.2∞, c 0.20 CHCl 3 , 330 mg) (Nicollier et al., 1979) was isolated as white needles from EtOAc. Fractions 9Ð10 afforded dehydrocanophyllic acid methyl ester (1) (m.p. 243Ð245 ∞C, α D Ð 30.0∞, c 0.27 CHCl 3 , 96 mg) (Govindachari et al., 1967) . Fraction 11 produced 2 (m.p. 213Ð215 ∞C from CHCl 3 /MeOH, α D Ð 13.5∞, c 0.20 CHCl 3 , 15.1 mg) (Betancor et al., 1980) . Fractions 34Ð48 (5.1 g) were submitted to VCC (30 ¥ 5 cm, 75 g) with hexane/EtOAc 9:1 v/v to produce 4 (20 mg). From fractions 49Ð80 (8.2 g) mortonin C (11) (white crystals from EtOAc, m.p. 205Ð207 ∞C, α D 58.7∞, c 0.18 CHCl 3 , 987 mg) , 3 (1.37 g) and 4 (305 mg) were isolated after a VCC (30 ¥ 6.0 cm, 120 g) eluted with hexane/EtOAc 9:1 v/v. Fractions 81Ð111 produced by VCC 11 (1.2 g), 3 (230 mg) and photomortonin C (12) (white prisms from hexane/EtOAc, m.p. 178Ð180 ∞C, α D 47.8∞, c 0.25 CHCl 3 , 140 mg) (Sá nchez et al., 1984) .
The acetonic root extract (9.0 g) was worked up as above to afford compounds 3 (500 mg), 4 (384 mg), 8 (300 mg) and 6 (800 mg). All mentioned compounds were identified by comparison of their spectral features with those reported in literature. Copies of the original spectra are available from the author of correspondence.
Reagents
Carrageenan (carrageenan kappa type III), 12-O-tetradecanoylphorbol-13-acetate (TPA), indomethacin, dexamethasone, aminoguanidine, and lipopolysaccharide (LPS) (Escherichia coli, Serotipe 055:B5) were obtained from Sigma Chemical Co. (St. Louis, MO, USA). Dulbecco's modified essential medium (DMEM) and fetal bovine serum (FBS) were obtained from GIBCO (Grand Island, NY, USA). Brewer thioglycolate medium was from DIFCO ( Detroit, MI, USA).
Animals
Male NIH mice and Wistar rats, weighing 25Ð 30 g and 150Ð200 g, respectively, were provided by the Instituto de Fisiología Celular, UNAM, and approved by the Animal Care and Use Committee (No. NOM-06ZZ00 1999). All animals were conditioned in standard laboratory conditions in the animal house (temperature 27 ð 1 ∞C) in a 12/12 h light-dark cycle. They were fed laboratory diet and water ad libitum. All experiments were carried out using 4Ð8 animals per group.
Anti-inflammatory tests
The carrageenan-induced paw edema test in rats was carried out on compounds 1, 4Ð11 as previously described (Martínez-Vá zquez et al., 1997) . Compounds were dissolved in DMSO/methylcellulose (1:10) and administered at 20 mg/kg and the average volume of the back-paw was determined by means of three or four measurements 1, 3 and 5 h after the injection of the inflammatory agent. The cumulative anti-inflammatory effect during the whole observation period was determined by the area under the curve (AUC). Percentages of inhibition (% I) were obtained for each group and at each record from the equation:% I = (AUC control Ð AUC treat) · 100/AUC control. Indomethacin was used as reference compound (Table I).
The TPA-induced ear edema assay in mice was performed as previously reported (Pé rez-Castorena et al., 2001) . Compounds 1, 4, 7, and 8 were dissolved in CH 2 Cl 2 , 5 and 6 in EtOAc/hexane 1:1 v/v mixture, 9 and 3 in methanol and 11 in acetone. Control animals received only the correspondent solvent in each case. Edema inhibition (EI%) was calculated by means of the equation: EI% = 100 Ð (B ¥ 100/A), where A is the edema induced by TPA alone and B the edema induced by TPA plus sample. Indomethacin, dissolved in ethanol, was the reference compound (Table II) .
Assay of NO production in activated macrophages (Mφ)
To obtain primary Mφ, NIH mice were injected with 1 ml of 3% (w/v) thioglycolate broth (Fushiya et al., 1999) . After three days, the peritoneal exudate cells (PEC) were washed out with DMEN through the anterior abdominal wall. The PEC were then suspended in culture medium at 1 ¥ 10 6 cells/ml and incubated for 2 h in 24 well tissue culture plates in a humidified CO 2 incubator. Nonadherent cells were gently washed out twice with a fresh medium. Remaining adherent cells were cultured in the same medium containing 10 µg/ml LPS with or without test sample for 24 h. Compounds 1, 4, 5, 6, 8, and 11 were dissolved in DMSO, and compounds 7, 9, and 10 were applied in ethanolic solution. The amount of nitrite, an indicator of NO synthesis in the culture supernatants, was measured by the Griess reaction (Dirsch et al., 1998) by adding 100 µl of Griess reagent (1% sulfanilamide/0.1% naphthylethylenediamine dihydrochloride/5% H 3 PO 4 ) to 100 µl of supernatant. After the chromophore was formed at room temperature for 10 min, absorbance was determined at 515 nm using a microplate reader (BioTek instruments, Vermont, USA) and the nitrite concentration was determined by interpolation using a calibration curve of standard sodium nitrite concentration vs. absorbance. All assays were performed in four replicates and repeated in at least three independent experiments. Inhibition of nitrite production by tested compounds was calculated by the equation: I% = 100 Ð (C ¥ 100/D). C represents the nitrite production by LPS alone, and D the nitrite production by LPS plus sample. Aminoguanidine and dexamethasone were used as reference compounds. (Tabel III).
Cell respiration, as indicator of cell viability, was analyzed in the remaining Mφ by the MTT method (Mosmann, 1983) . MTT solution (10 µl) of 5 mg/ml in PBS was added to each well, and the mixture was incubated for 4 h at 37 ∞C. The reduced MTT-formazan was dissolved in 100 µl dimethylsulfoxide (DMSO), absorbance of this solution at 570 nm was read using a microplate reader. Results were expressed in absolute absorbance readings and a decrease of absorbance indicates reduction in cell viability. Data were expressed as cytotoxicity percentage.
Statistical analysis
All data were represented as percentage mean ð standard error of mean (SEM). The statistical analysis was done by means of Student's t-test, whereas analysis of variance (ANOVA) and Dunnett's test were used to compare several groups with a control. The IC 50 values were estimated by means of a linear regression equation.
Results
The anti-inflammatory tests, the ability to inhibit NO and the cell viability tests, were determined for compounds 1 and 4Ð11 (Fig. 1) .
In the carrageenan model (Table I ) the friedelan dehydrocanophyllic acid methyl ester (1) was the most active of the tested compounds, its highest effect was observed 3 h after the carrageenan application. This action decreased considerably in the free acid 4. The lupane derivative 29-hydroxylupeol (6) showed the highest percentage of edema inhibition with a maximum after 5 h; this activity lowered in lupeol (5) (2), 30-hydroxyfriedelan-3-one (3), dehydrocanophyllic acid (4), lupeol (5), 29-hydroxylupeol (6), 29-hydroxylupenone (7), retusine (8), 6-acetoxy-1,9-dibenzoyloxy-4-hydroxydihydro--agarofuran (9), 1,2,6,14-tetraacetoxy-9-benzoyloxydihydro--agarofuran (10), mortonin C (11), photomortonin C (12). penone (7). Retusine (8) was an active compound with the maximum effect after 3 h. The agarofuran 9 showed mild anti-inflammatory capacity. Compounds 10 and 11 presented no activity. All tested compounds affected the TPA-induced edema in a dose-dependent manner except for compounds 6 and 11 which did not reduce inflammation (Table II) . The friedelan 4 was the most potent of the tested compounds; this activity was considerably diminished for its methyl ester 1. Lupeol (5) showed significant anti-inflammatory action, as already reported (Recio et al., 1995) . This effect lowered for 29-hydroxylupenone (7). TPA tests on 29-hydroxylupeol (6) could not be satisfactorily performed due to its lack of solubility. Retusine (8) presented significant activity and the agarofuran derivatives 9 and 10 exhibited moderate IC 50 values.
In the case of NO produced by activated Mφ (Table III) , the dehydrocanophyllic acid methyl ester (1) showed a weak inhibition and no cytotoxicity, in contrast to the free acid 4 which showed high cytotoxicity and a slight activity. Lupeol (5), in agreement with the reported data (Ferná ndez et al., 2001) , and 29-hydroxylupeol (6) showed a modest activity, in contrast 29-hydroxylupenone (7) exhibited NO inhibition capacity similar to aminoguanidine, although its cytotoxicity was also enhanced. The flavonoid 8 and mortonin (11) were weak active non-toxic compounds. The two agarofuran derivatives 9 and 10 presented NO inhibition values similar to that of aminoguanidine but a different degree of cytotoxicity. 
Discussion
The TPA has been reported to produce a long lasting inflammatory response associated with a marked cellular influx and a moderate eicosanoid production (Rao et al., 1993) . It is a powerful protein kinase C activator (Huguet et al., 2000) whose edema is inhibited by both COX and 5-LOX inhibitors (Hara et al., 1992) .
The carrageenan model, which has been described as the best predictor of human doses (Mukherjee et al., 1996) , is characterized by the production of a biphasic edema. In the relatively rapid early phase (up to 2 h) the edema formation is governed by the presence of histamine, bradykinin and 5-hydroxytryptamine. In the late phase (2 h to 6 h) prostanoid synthesis induced by COX-2 and NO synthesized by iNOS are reported to contribute to the edema (Di Rosa, 1972; Omote et al., 2001) .
Murine Mφ when stimulated by bacterial products (i. e. LPS or cytokines) produced by action of iNOS a large amount of NO, which is an important agent in the edema development. Therefore, the inhibitory effect on NO production in LPS activated Mφ is an useful way of evaluation of the anti-inflammatory activity (Fushiya et al., 1999) Based on the results, the activity of dehydrocanophyllic acid methyl ester (1) could be related to an inhibition of prostaglandin and NO production. No cytotoxic effects on Mφ were observed. For the free acid 4 it might be deduced that its high effect on the TPA edema obey to a different mechanism, it was also clear an increment of its cytotoxicity in relation with its methyl ester 1. In the lupanes, the presence of the two hydroxy groups in 29-hydroxylupeol (6) appears to be related to its activity in the carrageenan model, since lupeol (5) and 29-hydroxylupenone (7) exhibited a modest edema inhibition. On the edema produced by TPA 5 was more active than 7, showing that the hydroxy group on position 3 enhances the activity. On the other hand, cytotoxicity followed an increasing tendency, 5 < 6 < 7, showing again the effect of the presence of hydroxy groups at positions 3 and 29. In summary, the activity of the lupane skeleton compounds 5Ð7 could be involved with the prostanoid synthesis and their possible role in the NO inhibition could not be established due to the observed cytotoxicity. The flavonoid 8 showed significant action in both carrageenan and TPA models, with a weak NO inhibition effect, indicating that the highest component of its activity could be associated, here again, with the prostaglandin synthesis. The agarofuran derivative 9 exhibited modest effects in the anti-inflammatory tests, suppressed the NO production but exerted cytotoxic action towards Mφ. On the other hand, compound 10 showed low activity in TPA, no activity in the carrageenan model, and its NO inhibition, with no cytotoxicity, was similar to the one observed for aminoguanidine indicating that its activity could be related to an action on the iNOS and is probably not related to prostaglandin synthesis. The latter, also suggests a different mechanism of action in 9 and 10 due to their different substitution pattern.
